RYHTY OTC
Ryman Healthcare Limited
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: -26.5%
1Y: -14.1%
3Y: -67.1%
5Y: -88.1%
$6.11
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$12.3B
+2.0% ▲
5Y CAGR: +6.1%
Total Liabilities
$8.2B
+5.3% ▲
5Y CAGR: +5.3%
Shareholders Equity
$4.1B
-4.0% ▼
5Y CAGR: +7.7%
Cash & Investments
$10M
-44.9% ▼
5Y CAGR: -13.6%
Total Debt
$1.6B
-5.8% ▼
5Y CAGR: -6.9%
Net Debt
$1.6B
-5.4% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $28M | $28M | $42M | $18M | $10M |
| Short-Term Investments | $0 | $0 | $10M | $0 | $0 |
| Cash & ST Investments | $28M | $28M | $52M | $18M | $10M |
| Net Receivables | $687M | $719M | $695M | $141M | $166M |
| Inventory | $26M | $15M | $2M | $13K | $12K |
| Other Current Assets | $0 | $31M | $76M | $33M | $0 |
| Total Current Assets | $741M | $776M | $825M | $216M | $176M |
| Property, Plant & Equip. | $2.1B | $2.2B | $1.9B | $1.0B | $1.1B |
| Goodwill & Intangibles | $52M | $85M | $85M | $14M | $10M |
| Long-Term Investments | $8.0B | $9.4B | $10.0B | $10.8B | $11.0B |
| Other Non-Current Assets | $0 | $31M | $0 | $1M | $42M |
| Total Non-Current Assets | $10.2B | $11.7B | $12.3B | $11.8B | $12.1B |
| Total Assets | $11.0B | $12.5B | $13.1B | $12.1B | $12.3B |
| — Liabilities — | |||||
| Accounts Payable | $79M | $108M | $118M | $85M | $72M |
| Short-Term Debt | $0 | $118M | $0 | $0 | $150M |
| Deferred Revenue | $81M | $99M | $141M | $184M | $0 |
| Other Current Liabilities | -$41M | -$167M | $82M | $592M | $24M |
| Total Current Liabilities | $304M | $256M | $373M | $890M | $319M |
| Long-Term Debt | $2.6B | $2.2B | $2.5B | $1.7B | $1.4B |
| Other Non-Current Liab. | $308M | $523M | $423M | $5.2B | $6.2B |
| Total Non-Current Liabilities | $7.2B | $7.6B | $8.3B | $6.9B | $7.9B |
| Total Liabilities | $7.5B | $7.8B | $8.7B | $7.8B | $8.2B |
| — Equity — | |||||
| Common Stock | $33M | $953M | $953M | $1.9B | $1.9B |
| Retained Earnings | $3.0B | $3.1B | $3.1B | $2.2B | $2.0B |
| Accumulated OCI | $473M | $634M | $383M | $109M | $190M |
| Total Stockholders Equity | $3.4B | $4.7B | $4.4B | $4.3B | $4.1B |
| Total Liabilities & Equity | $11.0B | $12.5B | $13.1B | $12.1B | $12.3B |
| — Key Metrics — | |||||
| Total Debt | $2.6B | $2.3B | $2.6B | $1.7B | $1.6B |
| Net Debt | $2.6B | $2.3B | $2.5B | $1.7B | $1.6B |
| Total Investments | $8.1B | $9.4B | $10.0B | $10.8B | $11.0B |